Who are Plasma-lyte's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Plasma-lyte (dynamic group), Plasma-lyte (static group).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/plasma-lyte.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Plasma-lyte — Competitive Intelligence Brief

Plasma-lyte (Plasma-lyte) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Crystalloid intravenous fluid / Electrolyte replacement solution. Area: Critical Care / Fluid and Electrolyte Management.

marketed Crystalloid intravenous fluid / Electrolyte replacement solution Critical Care / Fluid and Electrolyte Management Small molecule Live · refreshed every 30 min

Target snapshot

Plasma-lyte (Plasma-lyte) — Fundación Santa Fe de Bogota. Plasma-Lyte is a balanced electrolyte solution that replaces fluid and electrolytes lost through dehydration, hemorrhage, or other medical conditions.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Plasma-lyte TARGET	Plasma-lyte	Fundación Santa Fe de Bogota	marketed	Crystalloid intravenous fluid / Electrolyte replacement solution
Plasma-lyte (dynamic group)	Plasma-lyte (dynamic group)	Algemeen Ziekenhuis Maria Middelares	marketed	Crystalloid intravenous fluid / Electrolyte replacement solution
Plasma-lyte (static group)	Plasma-lyte (static group)	Algemeen Ziekenhuis Maria Middelares	marketed	Crystalloid intravenous fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Crystalloid intravenous fluid / Electrolyte replacement solution class)

Algemeen Ziekenhuis Maria Middelares · 2 drugs in this class
Fundación Santa Fe de Bogota · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Plasma-lyte — Competitive Intelligence Brief. https://druglandscape.com/ci/plasma-lyte. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab